Fairfield Financial Advisors, LTD Abbott Laboratories Transaction History
Fairfield Financial Advisors, LTD
- $285 Billion
- Q2 2025
A detailed history of Fairfield Financial Advisors, LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Fairfield Financial Advisors, LTD holds 7,222 shares of ABT stock, worth $946,226. This represents 0.34% of its overall portfolio holdings.
Number of Shares
7,222
Previous 9,809
26.37%
Holding current value
$946,226
Previous $1.3 Billion
24.51%
% of portfolio
0.34%
Previous 0.49%
Shares
13 transactions
Others Institutions Holding ABT
# of Institutions
3,580Shares Held
1.39BCall Options Held
9.73MPut Options Held
9.08M-
Vanguard Group Inc Valley Forge, PA173MShares$22.6 Billion0.39% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.7MShares$10.2 Billion0.44% of portfolio
-
Capital International Investors Los Angeles, CA60.1MShares$7.88 Billion1.47% of portfolio
-
Capital Research Global Investors Los Angeles, CA41.8MShares$5.47 Billion1.19% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $229B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...